Skip to main content

Drug Interactions between Akynzeo for Injection and apomorphine

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

palonosetron apomorphine

Applies to: Akynzeo for Injection (fosnetupitant / palonosetron) and apomorphine

Using palonosetron and apomorphine is not recommended. Taking these drugs together can cause symptoms of feeling light-headed, loss of consciousness, chest pain or heavy feeling, or tremors. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Drug and food interactions

Moderate

apomorphine food

Applies to: apomorphine

Alcohol can lower your blood pressure and add to the effects of apomorphine. Drinking alcohol while taking apomorphine may decrease your blood pressure and cause drowsiness. This can cause nausea, extreme drowsiness, slow heartbeat, headaches, and dizziness. If you take apomorphine with alcohol tell your doctor if you have any of these symptoms. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.